Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer.
about
Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan.Targeted therapies for gastric cancer: current status.Programmed chemotherapy for patients with metastatic unresectable gastric cancer.Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer.Histological evaluation for chemotherapeutic responses of metastatic lymph nodes in gastric cancer.Treatment strategies for gastric cancer patients with peritoneal metastasis.High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan.Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy.Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer.Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.A phase I study of S-1 in combination with nab-paclitaxel in patients with unresectable or recurrent gastric cancer.A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer.
P2860
Q33594906-EEF10180-A378-42AD-8673-225A3BBC1049Q34205672-F2362AC1-E4B2-46FA-9FCC-31D2771A2551Q34325743-3B5D62A9-9F2B-40F0-9322-40B12DAD2A37Q36075265-7413CCB9-99B2-43E3-9832-26AEE45E339EQ36401587-4F21B9C8-5158-4E89-9A4C-9E70102B3500Q38107140-9D31A99A-F4D8-43BF-990D-5CFBD0064E1EQ38882319-838D377D-1BD0-41BB-ABED-6DB9ABA7F7F9Q38986946-1C018C45-7261-4038-A0B9-8F69087362ACQ39726150-42A400A9-6639-42CD-95D8-07AF4894061EQ44441494-393DEB67-9CC7-4759-8211-29FB0195DC41Q45928405-8656F3ED-229B-47D2-9A44-2E32D77D7A7BQ46822414-FF2F711C-B76B-49EE-8765-341A9F5A2417Q53099235-7399B63C-F3A9-427C-9149-47ED743DC470Q53492933-2BDE1705-6AA5-4D96-9803-2887B90567E0
P2860
Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Phase I/II study of S-1 combin ...... rrent advanced gastric cancer.
@ast
Phase I/II study of S-1 combin ...... rrent advanced gastric cancer.
@en
type
label
Phase I/II study of S-1 combin ...... rrent advanced gastric cancer.
@ast
Phase I/II study of S-1 combin ...... rrent advanced gastric cancer.
@en
prefLabel
Phase I/II study of S-1 combin ...... rrent advanced gastric cancer.
@ast
Phase I/II study of S-1 combin ...... rrent advanced gastric cancer.
@en
P2093
P2860
P356
P1476
Phase I/II study of S-1 combin ...... rrent advanced gastric cancer.
@en
P2093
J Nakamura
K Takeuchi
North Kanto Gastric Cancer Study Group
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603497
P407
P577
2006-11-28T00:00:00Z